Tuberculosis

Tuberculosis (TB) is a bacterial disease caused by members of the Mycobacterium tuberculosis complex ^[1]. The payload identifies it as Mycobacterium tuberculosis infection of the lungs, and the review literature also discusses both pulmonary and extra-pulmonary disease ^[1]. The sources support a classification as a major infectious disease of enduring global importance, but more granular etiologic or pathogenic detail is not provided in the snippets ^[1].

The available sources indicate that tuberculosis can present as pulmonary tuberculosis and extra-pulmonary tuberculosis, but they do not provide a detailed symptom list in the snippets supplied ^[1]. Management guidance notes that clinical and public-health decisions are influenced by comorbidities, severity of disease, and response to treatment ^[2]. Tuberculous meningitis is identified as the most severe form of tuberculosis and is reported to cause death or disability in around half of those affected ^[3]. Beyond this, source-backed detail on the usual course, complication profile, or symptom chronology is not yet available ^[1][3].

Tuberculosis is described as a major cause of death worldwide and a major killer of the human population after HIV/AIDS according to the reviewed source ^[1]. The same review states that TB is highly prevalent among people in low socioeconomic settings and marginalized communities ^[1]. One guideline also emphasizes the public-health importance of prompt diagnosis and effective management in children and adults ^[2]. Specific incidence figures, country-level burden, or outbreak patterns are not provided in the supplied snippets, so those details are not yet available from source-backed evidence ^[1][2].

The provided sources do not state the transmission route or exposure mechanism for tuberculosis ^[1][2][3]. They do, however, frame TB as a mycobacterial infection requiring prompt diagnosis and effective management because of its public-health implications ^[2]. Source-backed detail on airborne spread, infectious period, or environmental persistence is not yet available in the supplied material ^[1][2].

The review source states that tuberculosis is highly prevalent among people in low socioeconomic settings and marginalized sections of the community ^[1]. Beyond this, the provided snippets do not specify age groups, occupational exposures, immunologic risk states, or other high-risk populations in a source-backed way ^[1][2][3].

The guideline source emphasizes prompt diagnosis and effective management as central public-health measures for tuberculosis ^[2]. It also notes that clinical and public-health management should be informed by available cultures, molecular and phenotypic drug susceptibility testing, and radiographic studies in routine practice settings ^[2]. The review source indicates a national goal of elimination in India by 2025, but the snippets do not provide specific prevention strategies such as vaccination, contact tracing, or exposure-control measures ^[1][2].

In surveillance contexts, tuberculosis should be interpreted as a long-recognized, high-burden bacterial disease with substantial public-health significance and an important lethal potential ^[1][2]. The presence of extra-pulmonary disease, particularly tuberculous meningitis, may signal severe illness because this form is reported to be the most severe and to cause death or disability in around half of affected patients ^[3]. The supplied sources support attention to severity, comorbidity, and treatment-response as relevant management dimensions, but detailed monitoring thresholds or reporting definitions are not provided here ^[2][3].

1. 1 Natarajan A et al. A systemic review on tuberculosis. Indian J Tuberc. 2020 Jul. PMID: 32825856. doi: 10.1016/j.ijtb.2020.02.005. PubMed: https://pubmed.ncbi.nlm.nih.gov/32825856/
2. 2 Nahid P et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016 Oct 1. PMID: 27516382. doi: 10.1093/cid/ciw376. PubMed: https://pubmed.ncbi.nlm.nih.gov/27516382/
3. 3 Donovan J et al. A clinical practice guideline for tuberculous meningitis. Lancet Infect Dis. 2026 Feb. PMID: 40840485. doi: 10.1016/S1473-3099(25)00364-0. PubMed: https://pubmed.ncbi.nlm.nih.gov/40840485/
4. 4 Tuberculosis (Mycobacterium tuberculosis). Nelson Textbook of Pediatrics. 2011. doi: 10.1016/b978-1-4377-0755-7.00207-4. DOI: https://doi.org/10.1016/b978-1-4377-0755-7.00207-4
5. 5 Mycobacterium tuberculosis: Tuberculosis, TB. Encyclopedia of Intensive Care Medicine. 2012. doi: 10.1007/978-3-642-00418-6_1911. DOI: https://doi.org/10.1007/978-3-642-00418-6_1911
6. 6 Tuberculosis or not tuberculosis. Indian Journal of Medical Research. 2020. doi: 10.4103/ijmr.ijmr_2156_19. DOI: https://doi.org/10.4103/ijmr.ijmr_2156_19

ICD-10

A15-A19

ICD-11

1B10

Total cases

19.3M

Total deaths

37K

Peak month

2010-03

Coverage

8 reporting countries · 2000-01-01 → 2026-06-20